Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

doctor's chemicals works ltd. - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

edcl (dhaka) - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

hudson pharmaceuticals ltd. - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

indo-bangla pharmaceuticals ltd. - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

indo-bangla pharmaceuticals ltd. - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

monicopharma limited - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

pharmadesh laboratories ltd. - riboflavin - tablet - 5 mg

Bangla Desh - anglès - DGDA (Directorate General of Drug Administration)

united chemicals & pharmaceuticals ltd. - riboflavin - tablet - 5 mg

Israel - anglès - Ministry of Health

neopharm scientific ltd - eribulin as mesilate - solution for injection - eribulin as mesilate 0.44 mg/ml - eribulin - halaven is indicated for the treatment of adult patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting unless patients were not suitable for these treatments.halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease.